title: 'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer.
authors.affiliation: Medical Oncology Department, University Campus Bio-Medico, Rome, Italy. Electronic address: d.santini@unicampus.it.
authors.forename: D
authors.initials: D
authors.lastname: Santini
authors.affiliation: Medical Oncology Department, University Campus Bio-Medico, Rome, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Vincenzi
authors.affiliation: Medical Oncology Department, University Campus Bio-Medico, Rome, Italy; INSERM, Research Unit U1033, University of Lyon-1, Faculty of Medicine Laennec, Lyon, France.
authors.forename: F
authors.initials: F
authors.lastname: Pantano
authors.affiliation: Breast Unit, The Royal Marsden NHS Foundation Trust, London, UK.
authors.forename: G
authors.initials: G
authors.lastname: Schiavon
authors.affiliation: Medical Oncology Department, University Campus Bio-Medico, Rome, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Tonini
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics*; D004938:Esophageal Neoplasms / Q000235:genetics*; D004943:Esophagogastric Junction / Q000473:pathology*; D005260:Female; D005784:Gene Amplification; D006801:Humans; D008297:Male; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*; D013274:Stomach Neoplasms / Q000235:genetics*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human